Jasco Pharmaceuticals, LLC

Calculating rank

USPTO Granted Patents = 7

% Expired Patents = 14.3

CIPO Patents = 3

EPO Patents = 3

Forward Citations = 41

Loading Chart...

6 inventors (with patents filed for the assignee):

Carmen M Baldino (7 out of 9 patents)

Justin L Caserta (7 out of 7 patents)

Chee-Seng Lee (7 out of 7 patents)

4. Stephane A Dumas (6 out of 12 patents)

5. Yvonne L Flanders (6 out of 6 patents)

6. Robert B Nicewonger (3 out of 11 patents)

7 patents: Sort by Forward Citations

1. 10336743 - Aminopyrimidine kinase inhibitors (2019-07-02),

2. 9629840 - Aminopyrimidine kinase inhibitors (2017-04-25),

3. 9157077 - Aminopyrimidine kinase inhibitors (2015-10-13),

4. 9073903 - Imidazole-2,4-dione inhibitors of casein kinase 1 (2015-07-07),

5. 8927525 - Aminopyrimidine kinase inhibitors (2015-01-06),

6. 8901145 - Aminopyrimidine kinase inhibitors (2014-12-02),

7. 8563539 - Aminopyrimidine kinase inhibitors (2013-10-22),

Company Overview

Jasco Pharmaceuticals is a leading pharmaceutical company focused on developing and commercializing innovative medicines to address unmet medical needs. With a strong commitment to research and development, we aim to improve patient outcomes and quality of life. Our diverse portfolio includes a range of therapeutic areas, such as oncology, cardiovascular, and rare diseases. For more information, please visit our website.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#81 in Woburn, MA

#2,307 in Massachusetts

#39,950 in US

Woburn, MA, United States of America

Jasco Pharmaceuticals, LLC

Forward Citations = 41

6 inventors:

Carmen M Baldino (7 out of 9 patents)

Justin L Caserta (7 out of 7 patents)

Chee-Seng Lee (7 out of 7 patents)

4. Stephane A Dumas (6 out of 12 patents)

5. Yvonne L Flanders (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jasco Pharmaceuticals, LLC. Retrieved from https://idiyas.com/company/jasco-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]